Rachel Stolzenberg-Solomon, PhD, MPH

• Charles Fuchs
• Harvey Risch
• Herbert Yu
• Lingeng Lu
• Melinda Irwin
• Nathaniel Rothman

Biomarkers; Cancer; Nutrition

• The Healthy Eating Index 2005 and risk for pancreatic cancer in the NIH-AARP study.Arem H, Reedy J, Sampson J, Jiao L, Hollenbeck AR, Risch H, Mayne ST, Stolzenberg-Solomon RZ. The Healthy Eating Index 2005 and risk for pancreatic cancer in the NIH-AARP study. Journal Of The National Cancer Institute 2013, 105: 1298-305. PMID: 23949329, PMCID: PMC3760780, DOI: 10.1093/jnci/djt185.
• Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort.Stolzenberg-Solomon RZ, Schairer C, Moore S, Hollenbeck A, Silverman DT. Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort. The American Journal Of Clinical Nutrition 2013, 98: 1057-65. PMID: 23985810, PMCID: PMC3778860, DOI: 10.3945/ajcn.113.058123.
• Vitamin D-binding protein and pancreatic cancer: a nested case-control study.Piper MR, Freedman DM, Robien K, Kopp W, Rager H, Horst RL, Stolzenberg-Solomon RZ. Vitamin D-binding protein and pancreatic cancer: a nested case-control study. The American Journal Of Clinical Nutrition 2015, 101: 1206-15. PMID: 25904602, PMCID: PMC4441803, DOI: 10.3945/ajcn.114.096016.
• Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes.Loftfield E, Freedman ND, Lai GY, Weinstein SJ, McGlynn KA, Taylor PR, Mannisto S, Albanes D, Stolzenberg-Solomon RZ. Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes. Cancer Prevention Research (Philadelphia, Pa.) 2016, 9: 866-874. PMID: 27574287, PMCID: PMC5093066, DOI: 10.1158/1940-6207.CAPR-16-0141.
• Identifying biomarkers of dietary patterns by using metabolomics.Playdon MC, Moore SC, Derkach A, Reedy J, Subar AF, Sampson JN, Albanes D, Gu F, Kontto J, Lassale C, Liao LM, Männistö S, Mondul AM, Weinstein SJ, Irwin ML, Mayne ST, Stolzenberg-Solomon R. Identifying biomarkers of dietary patterns by using metabolomics. The American Journal Of Clinical Nutrition 2017, 105: 450-465. PMID: 28031192, PMCID: PMC5267308, DOI: 10.3945/ajcn.116.144501.
• Childhood body mass index and risk of adult pancreatic cancer.Nogueira L, Stolzenberg-Solomon R, Gamborg M, Sørensen TIA, Baker JL. Childhood body mass index and risk of adult pancreatic cancer. Current Developments In Nutrition 2017, 1 PMID: 29388617, PMCID: PMC5788457, DOI: 10.3945/cdn.117.001362.
• Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.Gordon-Dseagu VL, Devesa SS, Goggins M, Stolzenberg-Solomon R. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data. International Journal Of Epidemiology 2018, 47: 427-439. PMID: 29149259, PMCID: PMC5913617, DOI: 10.1093/ije/dyx232.
• Effects of dietary sodium on metabolites: the Dietary Approaches to Stop Hypertension (DASH)-Sodium Feeding Study.Derkach A, Sampson J, Joseph J, Playdon MC, Stolzenberg-Solomon RZ. Effects of dietary sodium on metabolites: the Dietary Approaches to Stop Hypertension (DASH)-Sodium Feeding Study. The American Journal Of Clinical Nutrition 2017, 106: 1131-1141. PMID: 28855223, PMCID: PMC5611778, DOI: 10.3945/ajcn.116.150136.
• Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, Canzian F, Childs EJ, Hoskins JW, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan AA, Babic A, Bamlet WR, Beane-Freeman L, Berndt SI, Blackford A, Borges M, Borgida A, Bracci PM, Brais L, Brennan P, Brenner H, Bueno-de-Mesquita B, Buring J, Campa D, Capurso G, Cavestro GM, Chaffee KG, Chung CC, Cleary S, Cotterchio M, Dijk F, Duell EJ, Foretova L, Fuchs C, Funel N, Gallinger S, M Gaziano JM, Gazouli M, Giles GG, Giovannucci E, Goggins M, Goodman GE, Goodman PJ, Hackert T, Haiman C, Hartge P, Hasan M, Hegyi P, Helzlsouer KJ, Herman J, Holcatova I, Holly EA, Hoover R, Hung RJ, Jacobs EJ, Jamroziak K, Janout V, Kaaks R, Khaw KT, Klein EA, Kogevinas M, Kooperberg C, Kulke MH, Kupcinskas J, Kurtz RJ, Laheru D, Landi S, Lawlor RT, Lee IM, LeMarchand L, Lu L, Malats N, Mambrini A, Mannisto S, Milne RL, Mohelníková-Duchoňová B, Neale RE, Neoptolemos JP, Oberg AL, Olson SH, Orlow I, Pasquali C, Patel AV, Peters U, Pezzilli R, Porta M, Real FX, Rothman N, Scelo G, Sesso HD, Severi G, Shu XO, Silverman D, Smith JP, Soucek P, Sund M, Talar-Wojnarowska R, Tavano F, Thornquist MD, Tobias GS, Van Den Eeden SK, Vashist Y, Visvanathan K, Vodicka P, Wactawski-Wende J, Wang Z, Wentzensen N, White E, Yu H, Yu K, Zeleniuch-Jacquotte A, Zheng W, Kraft P, Li D, Chanock S, Obazee O, Petersen GM, Amundadottir LT. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nature Communications 2018, 9: 556. PMID: 29422604, PMCID: PMC5805680, DOI: 10.1038/s41467-018-02942-5.